| 2024 | 2023 | 2022 | 2021 | 2020 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 424,1 k € | +9.5% | 387,3 k € | +1.6% | 381,4 k € | +8.3% | 352,1 k € | +9.5% | 321,6 k € | |
| EBITDA | 423,5 k € | +9.5% | 386,8 k € | +1.4% | 381,3 k € | +8.3% | 352,0 k € | +9.6% | 321,1 k € | |
| Operating profit | 422,3 k € | +9.3% | 386,5 k € | +1.6% | 380,4 k € | +8.3% | 351,1 k € | +10.1% | 318,8 k € | |
| Profit/loss | 320,5 k € | +9.0% | 294,0 k € | +1.4% | 289,9 k € | +8.3% | 267,8 k € | +9.8% | 243,9 k € | |
| Equity | 126,5 k € | +26.6% | 100,0 k € | -87.6% | 807,5 k € | +56.0% | 517,7 k € | +107.2% | 249,9 k € | |
| Total assets | 348,2 k € | +10.5% | 315,2 k € | -61.0% | 808,4 k € | +54.8% | 522,2 k € | +59.7% | 327,0 k € | |
| Cash | 97,0 k € | +245.2% | 28,1 k € | -95.3% | 596,0 k € | +71.1% | 348,4 k € | +132.2% | 150,0 k € | |
| Debts | 221,6 k € | +3.0% | 215,2 k € | +24239.5% | 884,3 € | -80.5% | 4,5 k € | -94.1% | 77,1 k € | |
Source: Belgian Official Gazette
Private limited company · Langemark-Poelkapelle · incorporated on 24/09/2020
Private limited company profitable but thinly capitalised. Cash position rising (+245.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (126,5 k €) relative to earnings. The abridged model hides revenue.
Barbara Deconinck, Endocrinologie-Diabetologie is a Private limited company incorporated in 2020. Its main activity is: Specialist medical practice activities. Its registered office is in Langemark-Poelkapelle.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.